Sino Biopharmaceutical Ltd - Preferred Stock and Other Adjustments
Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Preferred-Stock-and-Other-Adjustments" stands at -0.2269 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2021.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.18 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is 1.18 Billion Hong Kong Dollars.
The 5 year change is -1.43 Billion Hong Kong Dollars.
The Serie's change in Hong Kong Dollars from it's minimum value, on 12/31/2024, to it's latest available value, on 06/30/2025, is +1.40 Billion.
The Serie's change in Hong Kong Dollars from it's maximum value, on 09/30/2020, to it's latest available value, on 06/30/2025, is -1.74 Billion.
Preferred Stock and Other Adjustments for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Preferred Stock and Other Adjustments | 905,699,262,464.00 |
 | Johnson & Johnson - Preferred Stock and Other Adjustments | 486,508,953,600.00 |
 | AbbVie Inc - Preferred Stock and Other Adjustments | 399,570,305,024.00 |
 | Roche Holding AG - Preferred Stock and Other Adjustments | 317,433,206,677.55 |
 | AstraZeneca PLC - Preferred Stock and Other Adjustments | 280,205,508,085.11 |